204 related articles for article (PubMed ID: 8084925)
1. Shifting depression.
Campbell IC; Marsden K; Powell JF
Psychol Med; 1994 May; 24(2):271-3. PubMed ID: 8084925
[No Abstract] [Full Text] [Related]
2. Independent evaluation of new drugs.
Ball CJ
Br J Psychiatry; 1991 Oct; 159():586-7. PubMed ID: 1661200
[No Abstract] [Full Text] [Related]
3. Noradrenergic and serotoninergic depression?
Yazici O; Aricioğlu F; Gürvit G; Uçok A; Taştaban Y; Canberk O; Ozgüroğlu M; Durat T; Sahin D
J Affect Disord; 1993 Feb; 27(2):123-9. PubMed ID: 8382710
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic mechanisms and the new antidepressants.
Stahl SM
Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
[No Abstract] [Full Text] [Related]
5. [Mechanism of action of antidepressants].
Llorca PM; Reine G; Wolf MA
Can J Psychiatry; 1993 Dec; 38(10):649-56. PubMed ID: 8313303
[TBL] [Abstract][Full Text] [Related]
6. [Status of amine hypotheses in depressive disorders].
Fritze J; Deckert J; Lanczik M; Strik W; Struck M; Wodarz N
Nervenarzt; 1992 Jan; 63(1):3-13. PubMed ID: 1314964
[TBL] [Abstract][Full Text] [Related]
7. [Behavior of 5-HT receptors during long-term antidepressant treatment and at discontinuation].
Fillion G
Encephale; 1995 Feb; 21 Spec No 1():3-6. PubMed ID: 7729352
[No Abstract] [Full Text] [Related]
8. Dysthymia and serotonin.
Lapierre YD; Ravindran A; Bakish D
Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():87-90. PubMed ID: 8201250
[No Abstract] [Full Text] [Related]
9. Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine.
Haddjeri N; Blier P; de Montigny C
Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():11-7. PubMed ID: 8930005
[TBL] [Abstract][Full Text] [Related]
10. Regulation of neurotransmitter receptors by desipramine and other antidepressant drugs: the neurotransmitter receptor hypothesis of antidepressant action.
Stahl SM
J Clin Psychiatry; 1984 Oct; 45(10 Pt 2):37-45. PubMed ID: 6090439
[TBL] [Abstract][Full Text] [Related]
11. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction?
Dinan TG
J Clin Psychiatry; 1996; 57 Suppl 4():14-8. PubMed ID: 8636061
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine: a novel antidepressant that has a dual mechanism of action.
Andrews JM; Ninan PT; Nemeroff CB
Depression; 1996; 4(2):48-56. PubMed ID: 9160640
[TBL] [Abstract][Full Text] [Related]
13. Regulation of recognition and action function of the norepinephrine (NE) receptor-coupled adenylate cyclase system in brain: implications for the therapy of depression.
Sulser F; Janowsky AJ; Okada F; Manier DH; Mobley PL
Neuropharmacology; 1983 Mar; 22(3 Spec No):425-31. PubMed ID: 6304560
[No Abstract] [Full Text] [Related]
14. Is there action beyond receptors?
Hrdina PD
J Psychiatry Neurosci; 1993 Mar; 18(2):57-9. PubMed ID: 8384874
[No Abstract] [Full Text] [Related]
15. Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders.
Sulser F
J Clin Psychiatry; 1987 Mar; 48 Suppl():12-8. PubMed ID: 3029044
[TBL] [Abstract][Full Text] [Related]
16. [Noradrenergic and serotoninergic brain structures and the auditory analyzer].
Khanbabian MV; Davtian MM
Usp Fiziol Nauk; 1988; 19(1):118-24. PubMed ID: 2834889
[No Abstract] [Full Text] [Related]
17. Antidepressant mechanisms.
Goldstein S
J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):142. PubMed ID: 8138512
[No Abstract] [Full Text] [Related]
18. The marketing of 5-hydroxytryptamine: depression or anxiety?
Healy D
Br J Psychiatry; 1991 Jun; 158():737-42. PubMed ID: 1873625
[No Abstract] [Full Text] [Related]
19. Antidepressant treatment and side effect considerations.
Tollefson GD
J Clin Psychiatry; 1991 May; 52 Suppl():4-13. PubMed ID: 2030103
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine dysfunction in depression.
Anand A; Charney DS
J Clin Psychiatry; 2000; 61 Suppl 10():16-24. PubMed ID: 10910013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
